Rise and Shine: Everything you need to know before the ASX opens

Good morning everyone and welcome to Rise and Shine on Tuesday, October 14, 2025. Here’s what you should know before the ASX opens today…

At 7am AEST Tuesday, ASX futures were up 0.31%, hinting at a decent start to the day.

Here’s what happened last night…

Wall Street recovers, especially tech

We could say something trite here, such as “what a difference a day makes” … but we’d never do that.

Wall Street has mopped up a fair bit of its blood from Friday and has a decent spring in step again, with the S&P 500 rising 1.58%, the Nasdaq +2.20%, and the Dow +1.33%.

The BBOO (Big Bloated Orange One, aka Trump) seems in a TACO kinda mood, dialling down his trade-war bluster, sending chipmakers and tech names flying back up again.

Broadcom led the charge, rocketing 10% on news it’s teaming up with OpenAI to crank out the chatbot maker’s first home-grown AI chips. That lit a fire under the rest of the sector – the Philly chip index jumped nearly 5%, while Nvidia and Micron joined in the rally.

What’s next insofar as catalysts go, then? It’s a bit hard for forecasters to … cast, when there’s no data available thanks to the ongoing US government shutdown. That said, traders are now turning to bank earnings, with JPMorgan, Goldman, Citi and Wells Fargo set to report amid the government data freeze.

Meanwhile, in the Middle East, the ceasefire appears real, with Hamas freeing the last living Israeli hostages from Gaza and Israel sending home Palestinian detainees as part of a deal pushed by Trump.

He might now be considering making his own “Peace Prize”. (Accordian hands) “Who was this Nobel guy anyway? This new prize will probably be the greatest prize anyone has ever seen,” he’s thinking to himself. (Probably. Almost certainly.)

Commodity/forex/crypto market prices

What got you talking

Also in the news…

Health Check: Catapult propels into the soccer talent-scouting big league.

Dr Boreham’s Crucible: ED nasal spray innovator arouses interest as it looks to rise again.

Kristie Batten: Axel REE hitting the high notes to draw rare earths and gallium interest.

Regenerative medicine is a new frontier for medical tech – and these ASX companies are at the forefront.

Trading halts

• Cedar Woods Properties (ASX:CWP) – dividend reinvestment plan
• Compumedics (ASX:CMP) – cap raise
• Catapult Sports (ASX:CAT) – acquisition and cap raise
• Trivarx (ASX:TRI) – extension of suspension pending cap raise and acquisition
• Elixir Energy (ASX:EXR) – results from Diona-1 exploration oil and gas well
• Xstate Resources (ASX:XST) – results from Diona-1 well
• Altair Minerals (ASX:ALR) – execution of definitive documents for Greater Oko project
• Lodestar Minerals (ASX:LSR) – material drilling results from Ned’s Creek prospect
• Haranga Resources (ASX:HAR) – cap raise
• Brazilian Rare Earths (ASX:BRE) – cap raise
• Dalaroo Metals (ASX:DAL) – acquisition of gold project in Cote d’Ivoire
• Kairos Minerals (ASX:KAI) – cap raise
• Cufe (ASX:CUF) – cap raise
• Skin Elements (ASX:SKN) – cap raise
• Aruma Resources (ASX:AAJ) – cap raise
• NH3 Clean Energy (ASX:NH3) – cap raise
• Lion Rock Minerals (ASX:LRM) – cap raise
• SRG Global (ASX:SRG) – strategic acquisition
• Biotron (ASX:BIT) – material acquisition and cap raise

At Stockhead, we tell it like it is. While Axel REE is a Stockhead advertiser, it did not sponsor this article.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.